Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. IONS
IONS logo

IONS News & Events

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

IONS News

Ionis Pharmaceuticals (IONS.US) Director Plans to Sell $4.35 Million in Common Stock via Form 144

5d agomoomoo

Ionis Pharmaceuticals to Participate in Multiple Investor Conferences

May 01 2026Newsfilter

Ionis Pharmaceuticals Q1 2026 Earnings Call Highlights

Apr 29 2026seekingalpha

Ionis (IONS) Q1 2026 Earnings Call Transcript

Apr 29 2026NASDAQ.COM

Ionis Pharmaceuticals Q1 Earnings Beat Expectations with 86.4% Revenue Growth

Apr 29 2026seekingalpha

Ionis Pharmaceuticals Q1 Earnings Announcement Scheduled

Apr 28 2026seekingalpha

GSK Receives FDA Priority Review for Hepatitis B Therapy

Apr 28 2026seekingalpha

FDA Accepts Priority Review for Bepirovirsen by GSK and Ionis

Apr 28 2026NASDAQ.COM

IONS Events

No data

No data

IONS Monitor News

Ionis Pharmaceuticals Receives FDA Priority Review for Zilganersen

Mar 25 2026

Ionis Pharmaceuticals Presents DAWNZERA Data at AAAAI 2026

Mar 05 2026

Ionis Pharmaceuticals Receives FDA Priority Review for Olezarsen

Mar 03 2026

Ionis Pharmaceuticals Reports Q4 Earnings Miss Amid Investor Conference Participation

Feb 25 2026

Ionis Pharmaceuticals reaches 52-week high amid positive trial results

Jan 07 2026

IONS.O Hits 52-Week High Amid Positive Momentum

Nov 24 2025

IONS Earnings Analysis

Ionis Pharma Earnings: Financial Growth & Strategy- Intellectia AI™
1 years ago

People Also Watch